Philips makes $2.8B acquisition to strengthen cardiac business: 5 details

Philips plans to purchase a remote cardiac diagnostics and monitoring technology company for $2.8 billion.

Five details:

1. On Dec. 18, Philips announced plans to acquire BioTelemetry, a company with technology that monitors more than 1 million patients remotely. BioTelemetry's portfolio includes wearable heart monitors, artificial intelligence-based data analytics and other services.

2. Philips will add BioTelemetry to its cardiac care portfolio, which already includes real-time patient monitoring, therapeutic devices, telehealth and informatics capabilities.

3. The acquisition will further Philips' strategy to become a leader for in-hospital as well as home-based healthcare products and technologies.

4. BioTelemetry and its around 1,900 employees will join Philips' Connected Care business. The business is expected to grow in the double-digits and reach an adjusted EBITA margin of more than 20 percent by 2025.

5. The transaction is expected to complete in the first quarter of 2021.

More articles on health IT:
10 emerging trends in health IT for 2021
Georgia hospital reports 550 daily cyberattack attempts on its Epic MyChart system
Mayo Clinic adds hot spot data to its COVID-19 map